(CBLL - CERIBELL INC)

company profile

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Ceribell (CBLL) is trading at 20.37

Open Price
20.4
Previous close
20.37
Previous close
20.37
P/E Ratio
0
Sector
Health Care
Shares outstanding
37872491
Index
R2000,R3000
Primary exchange
NASDAQ-NMS
ISIN
US15678C1027